Compare CURX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CURX | GXAI |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 11.7M |
| IPO Year | 2025 | 2022 |
| Metric | CURX | GXAI |
|---|---|---|
| Price | $0.48 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.4M | ★ 8.9M |
| Earning Date | 09-09-2025 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | N/A | $79.41 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.26 | $1.00 |
| 52 Week High | $9.18 | $2.96 |
| Indicator | CURX | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 44.79 |
| Support Level | $0.37 | $1.04 |
| Resistance Level | $0.51 | $1.31 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 63.18 | 1.16 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.